^99mTc-labeled monosaccharide kits: development methods and quality control.

Area of Science:

• Radiochemistry
• Nuclear Medicine
• Biochemistry

Background:

• Technetium-99m (Tc-99m) generators are crucial for nuclear medicine imaging.
• Developing stable and efficient Tc-99m elution methods is an ongoing area of research.
• Glucose derivatives offer potential as components for novel generator systems.

Purpose of the Study:

• To outline the experimental planning for creating standardized reagent kits for Tc-99m generators.
• To investigate the use of glucose derivatives in these reagent kits.
• To ensure the quality and efficacy of the final radiopharmaceuticals.

Main Methods:

• Systematic research into optimal quantities of substances, reducing agents, stabilizers, and auxiliary components.
• Development of lyophilized kits for improved stability and ease of use.
• Rigorous quality control procedures for the developed kits and resulting radiopharmaceuticals.
• In vivo testing using C57B1/6j mice with Lewis lung carcinoma.

Main Results:

• Successful planning and execution of an experiment to create standard reagent kits.
• Radiochemical purity of the prepared radiopharmaceuticals ranged from 90.0% to 99.0%.
• Demonstrated functional suitability of the developed preparations in a preclinical cancer model.

Conclusions:

• The developed procedure provides a method for creating standardized reagent kits for Tc-99m generators.
• The glucose derivative-based kits yield radiopharmaceuticals with high purity and demonstrated efficacy.
• This work contributes to the advancement of Tc-99m based diagnostic tools.